Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a deal worth over $120 million biobucks with genomics-focused Variant Bio. The alliance ...
CBSE Class 12 Biology Pre Board Sample Paper 2025-2026: The CBSE Class 12 Biology Pre-Board Exam 2026 will be conducted on 27 March 2026 (Friday). As the exam date approaches, students are preparing ...
ICSE Biology Specimen Paper 2026 for Class 10: The ICSE Biology Specimen Paper 2026 exam will be held on 13 March 2026, and students appearing for the CISCE Class 10 Board Exam are highly encouraged ...
On October 29, 2025, Bio-Rad Laboratories reported third-quarter earnings with sales of US$653 million and a net loss of US$341.9 million, while also completing a major share repurchase and announcing ...
Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad Third Quarter 2025 ...
Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third ...
LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, and Gencurix, Inc., a leading Korean developer of oncology testing solutions, today announced ...
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...
Bio-Rad Laboratories Inc. has introduced a new range of StarBright Dyes, providing greater choice and flexibility for spectral flow cytometry in immunology research. The first dye in the series, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results